Free Republic

In trials of ivermectin as a treatment for COVID-19, the relative risk of mortality varies with strongyloidiasis prevalence, according to research published online March 21 in JAMA Network Open. Avi Bitterman, M.D., from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues examined the association between regional prevalence of strongyloidiasis and ivermectin trial results for the outcome of mortality in a meta-analysis of randomized clinical trials using ivermectin as a treatment for COVID-19. Data were included from 12 trials, with 3,901 patients: four and eight trials took place in regions of high and low strongyloidiasis...

WSJ article on Ivermectin study

CNN vs Ivermectin CNN says study shows Ivermectin does not work -- but the study shows that it DOES work ! I posted essentially the same analysis twice, but Igor Chudov has a better presentation with screen shots from the study. So, the study showed that, for Ivermectin vs control group: 4 vs 10 were placed on mechanical ventilation 3 vs 10 died (so 3 Ivermectin patients died, vs 10 without Ivermectin). https://igorchudov.substack.com/p/cnn-vs-ivermectin?utm_source=url

Malaysian researchers found that treatment with the anti-parasite drug ivermectin did not prevent patients with COVID-19 from becoming severely ill in a randomized clinical trial published in the JAMA Internal Medicine journal on Friday. The researchers said their findings do not support the use of ivermectin for patients with COVID-19. The study enrolled 490 patients with mild to moderate illness at 20 hospitals and a COVID-19 quarantine center in Malaysia. Everyone received standard care; half the group also received ivermectin. Severe disease developed in 21.6% of the patients given ivermectin and in 17.3% of those who received only standard care,...

RALEIGH, N.C. (WNCN) - Researchers at Duke want to know if taking more ivermectin for longer will work better as a COVID-19 treatment. A study that is testing three repurposed medications as COVID treatments is expanding to evaluate the polarizing anti-parasitic drug ivermectin at a higher dose for a longer period of time. Dr. Adrian Hernandez, the executive director of the Duke Clinical Research Institute and the study’s administrative principal investigator, said modeling studies, published research and community interest “support investigating multiple doses and durations of ivermectin.” “This expansion will provide valuable data on the role of ivermectin and whether...

The results are in from the world’s largest study of ivermectin for COVID-19.Brazil has had over 23 million cases of COVID-19 since the pandemic began, with a 97% recovery rate.Researchers in Brazil found that regular use of ivermectin as a prophylactic agent was associated with significantly reduced COVID-19 infection, hospitalization and mortality rates.The study was conducted in Itajaí, a port city in the state of Santa Catarina, between July and December 2020. Study authors include FLCCC physicians Dr. Flavio Cadegiani and Dr. Pierre Kory. Lead author Dr. Lucy Kerr was approached by the mayor of Itajaí, after the city began...

"Getting your Horse-Faced Horse-Paste Democrat Friends to swallow this truth bomb is going to be like feeding a pill to a cat. It is a peer-reviewed research study on Ivermectin from Brazil. We analyzed data from a prospective, observational study of the citywide COVID-19 prevention with ivermectin program, which was conducted between July 2020 and December 2020 in Itajaí, Brazil. The results: “…regular use of ivermectin as a prophylactic agent was associated with significantly reduced COVID-19 infection, hospitalization, and mortality rates.” What does significant mean? According to the researchers, Ivermectin resulted in a 67% reduction in hospitalization and a 70%...

New Peer-Reviewed Study Shows Ivermectin ‘Significantly’ Reduces COVID Infections, Hospitalization, and Mortality RatesA newly released study from Brazil of over 150 thousand subjects found that regular prophylactic use of ivermectin “was associated with significantly reduced COVID-19 infection, hospitalization, and mortality rates.”The largest ivermectin study to date was conducted in Itajaí, Brazil, between July 2020 and December 2020. It recently passed rigorous peer-review and was published this week, Dr. Pierre Kory noted on Twitter.Background: Ivermectin has demonstrated different mechanisms of action that potentially protect from both coronavirus disease 2019 (COVID-19) infection and COVID-19-related comorbidities. Based on the studies suggesting efficacy in...

Abstract Viruses such as human cytomegalovirus (HCMV), human papillomavirus (HPV), Epstein–Barr virus (EBV), human immunodeficiency virus (HIV), and coronavirus (severe acute respiratory syndrome coronavirus 2 [SARS‐CoV‐2]) represent a great burden to human health worldwide. FDA‐approved anti‐parasite drug ivermectin is also an antibacterial, antiviral, and anticancer agent, which offers more potentiality to improve global public health, and it can effectively inhibit the replication of SARS‐CoV‐2 in vitro. This study sought to identify ivermectin‐related virus infection pathway alterations in human ovarian cancer cells. Stable isotope labeling by amino acids in cell culture (SILAC) quantitative proteomics was used to analyze human ovarian cancer...

Abstract In 2015, the Nobel Committee for Physiology or Medicine, in its only award for treatments of infectious diseases since six decades prior, honoured the discovery of ivermectin (IVM), a multifaceted drug deployed against some of the world’s most devastating tropical diseases. Since March 2020, when IVM was first used against a new global scourge, COVID-19, more than 20 randomized clinical trials (RCTs) have tracked such inpatient and outpatient treatments. Six of seven meta-analyses of IVM treatment RCTs reporting in 2021 found notable reductions in COVID-19 fatalities, with a mean 31% relative risk of mortality vs. controls. During mass IVM...

Tracy Beanz, from Uncover DC, exposed so much truth about COVID-19 and the supposed “vaccines” during this episode of The Jeff Dornik Show, you are going to have to make sure you listen to the entire thing. It’s non-stop truth bomb after truth bomb. Let’s start with how dangerous COVID-19 actually is. According to the FDA’s approval letter of the Pfizer-BioNTech mRNA “vaccine,” the very study they use to show that it’s 95% effective also shows that both the vaxxed and unvaxxed have a 99% chance of not getting COVID-19. Additionally, for those that do get COVID-19, if you are...

Excerpt from the article - "Early on, limited trials suggested that ivermectin may have activity against SARS-CoV-2 in cells exposed to high concentrations of the drug in laboratory tests. However, more recent trials have shown no benefit. In fact, achieving the plasma concentrations necessary for the antiviral efficacy detected in those studies would require administration of ivermectin doses up to 100-fold higher than those approved for in humans."

Conclusions: Meta-analyses based on 18 randomized controlled treatment trials of ivermectin in COVID-19 have found large, statistically significant reductions in mortality, time to clinical recovery, and time to viral clearance. Furthermore, results from numerous controlled prophylaxis trials report significantly reduced risks of contracting COVID-19 with the regular use of ivermectin. Finally, the many examples of ivermectin distribution campaigns leading to rapid population-wide decreases in morbidity and mortality indicate that an oral agent effective in all phases of COVID-19 has been identified.

OK, the headline is a bit like clickbait, I do not believe Ivermectin is useful, but I could be wrong. (Did I just say that?) A new study demonstrates how a rush to publish, (and possibly treat) may have resulted in poorly designed studies where a quiet signal is lost in an abundance of noise.While effective vaccines are an incredibly important part of the COVID-19 solution, none are completely effective, and so we do need anti-virals to reduce the severity of those who become infected. There have been many candidates that have come and gone, most recently Ivermectin as we...

No safety concern is anticipated that would prevent health authorities from assessing the use of Ivermectin against Covid-19 as a new indicationThe expert review written by a prominent toxicologist is an assessment of ivermectin medical safety profile It is based on an extensive analysis of over 350 articles plus clearly identified and accessible web sourcesThe analysis will be submitted shortly by the author for peer review to an internationally acknowledged journal MedinCell is making this review available immediately at www.medincell.com/ivermectin"Publications over the last few months show a significant body of clinical data and scientific knowledge supporting the efficacy of ivermectin...